Janus kinase 3 activity is necessary for phosphorylation of cytosolic phospholipase A2 and prostaglandin E2 synthesis by macrophages infected with Francisella tularensis live vaccine strain

Infection and Immunity

Volumn 82, Issue 3, 2014, Pages 970-982

  Brummett, Ashley M ^a   Navratil, Aaron R ^a   Bryan, Joshua D ^a   Woolard, Matthew D ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ARACHIDONIC ACID; CELL LINE; CYCLOOXYGENASE 2; CYTOSOL; DINOPROSTONE; FEMALE; FRANCISELLA TULARENSIS; JANUS KINASE 3; MACROPHAGES; MICE; MICE, INBRED C57BL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A2, CYTOSOLIC; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TULAREMIA;

EID: 84894278023     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01461-13     Document Type: Article

References (42)

1. Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, Carhart S. 1961. Tularemia vaccine study. II. Respiratory challenge. Arch. Intern. Med. 107: 702-714.
2. Conlan JW, Chen W, Shen H, Webb A, KuoLee R. 2003. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb. Pathog. 34:239-248. http://dx.doi.org/10.1016/S0882-4010(03)00046-9.
3. Baron GS, Nano FE. 1998. MglA and MglB are required for the intramacrophage growth of Francisella novicida. Mol. Microbiol. 29:247-259. http: //dx.doi.org/10.1046/j.1365-2958.1998.00926.x.
4. Barrigan LM, Tuladhar S, Brunton JC, Woolard MD, Chen CJ, Saini D, Frothingham R, Sempowski GD, Kawula TH, Frelinger JA. 2013. Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response. Infect. Immun. 81:2028-2042. http://dx.doi.org /10.1128/IAI.00207-13.
5. Jones CL, Napier BA, Sampson TR, Llewellyn AC, Schroeder MR, Weiss DS. 2012. Subversion of host recognition and defense systems by Francisella spp. Microbiol. Mol. Biol. Rev. 76:383-404. http://dx.doi.org/10.1128/MMBR.05027-11.
6. Woolard MD, Barrigan LM, Fuller JR, Buntzman AS, Bryan J, Manoil C, Kawula TH, Frelinger JA. 2013. Identification of Francisella novicida mutants that fail to induce prostaglandin E(2) synthesis by infected macrophages. Front. Microbiol. 4:16. http://dx.doi.org/10.3389/fmicb.2013.00016.
7. Woolard MD, Wilson JE, Hensley LL, Jania LA, Kawula TH, Drake JR, Frelinger JA. 2007. Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response. J. Immunol. 178:2065-2074. http://www.jimmunol.org/content/178/4/2065.long.
8. Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW. 1984. The role of arachidonic acid oxygenation products in pain and inflammation. Annu. Rev. Immunol. 2:335-357. http://dx.doi.org/10.1146/annurev.iy.02.040184.002003.
9. Takayama K, Garcia-Cardena G, Sukhova GK, Comander J, Gimbrone MA, Jr, Libby P. 2002. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J. Biol. Chem. 277:44147-44154. http://dx.doi.org/10.1074/jbc.M204810200.
10. Wilson JE, Katkere B, Drake JR. 2009. Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages. Infect. Immun. 77:4953-4965. http://dx.doi.org/10.1128/IAI.00844-09.
11. Elkins KL, Rhinehart-Jones TR, Culkin SJ, Yee D, Winegar RK. 1996. Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect. Immun. 64:3288-3293.
12. Woolard MD, Hensley LL, Kawula TH, Frelinger JA. 2008. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferonpositive T cells. Infect. Immun. 76:2651-2659. http://dx.doi.org/10.1128/IAI.01412-07.
13. Leslie CC. 2004. Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2. Prostaglandins Leukot Essent Fatty Acids 70: 373-376. http://dx.doi.org/10.1016/j.plefa.2003.12.012.
14. Murakami M, Kudo I. 2004. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog. Lipid Res. 43:3-35. http://dx.doi.org/10.1016/S0163-7827(03)00037-7.
15. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269-278. http: //dx.doi.org/10.1016/0092-8674(93)90666-E.
16. Harper KA, Tyson-Capper AJ. 2008. Complexity of COX-2 gene regulation. Biochem. Soc. Trans. 36:543-545. http://dx.doi.org/10.1042/BST0360543.
17. Qiu ZH, de Carvalho MS, Leslie CC. 1993. Regulation of phospholipase A2 activation by phosphorylation in mouse peritoneal macrophages. J. Biol. Chem. 268:24506-24513.
18. Xu F, Xu Z, Zhang R, Wu Z, Lim JH, Koga T, Li JD, Shen H. 2008. Nontypeable Haemophilus influenzae induces COX-2 and PGE2 expression in lung epithelial cells via activation of p38 MAPK and NF-kappa B. Respir. Res. 9:16. http://dx.doi.org/10.1186/1465-9921-9-16.
19. Telepnev M, Golovliov I, Sjostedt A. 2005. Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells. Microb. Pathog. 38:239-247. http://dx.doi.org/10.1016/j.micpath.2005.02.003.
20. Kumar S, Jiang MS, Adams JL, Lee JC. 1999. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 263:825-831. http://dx.doi.org/10.1006/bbrc.1999.1454.
21. Gao J, Tian J, Lv Y, Shi F, Kong F, Shi H, Zhao L. 2009. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci. 100:389-395. http://dx.doi.org/10.1111/j.1349-7006.2008.01053.x.
22. Koon HW, Zhao D, Zhan Y, Rhee SH, Moyer MP, Pothoulakis C. 2006. Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells. J. Immunol. 176:5050-5059. http://www.jimmunol.org/content/176/8/5050.long.
23. Sudbeck EA, Liu XP, Narla RK, Mahajan S, Ghosh S, Mao C, Uckun FM. 1999. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin. Cancer Res. 5:1569-1582.
24. Gijon MA, Spencer DM, Siddiqi AR, Bonventre JV, Leslie CC. 2000. Cytosolic phospholipase A2 is required for macrophage arachidonic acid release by agonists that do and do not mobilize calcium. Novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A2 regulation. J. Biol. Chem. 275:20146-20156.
25. Flati V, Haque SJ, Williams BR. 1996. Interferon-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 is required for the formation of interferon-stimulated gene factor three. EMBO J. 15: 1566-1571.
26. Yellaturu CR, Rao GN. 2003. Cytosolic phospholipase A2 is an effector of Jak/STAT signaling and is involved in platelet-derived growth factor BBinduced growth in vascular smooth muscle cells. J. Biol. Chem. 278:9986-9992. http://dx.doi.org/10.1074/jbc.M211276200.
27. Xuan YT, Guo Y, Zhu Y, Han H, Langenbach R, Dawn B, Bolli R. 2003. Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J. Mol. Cell. Cardiol. 35:525-537. http://dx.doi.org/10.1016/S0022-2828(03)00076-2.
28. Yu H, Liu Z, Zhou H, Dai W, Chen S, Shu Y, Feng J. 2012. JAK-STAT pathway modulates the roles of iNOS and COX-2 in the cytoprotection of early phase of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress. Neurosci. Lett. 529:166-171. http://dx.doi.org /10.1016/j.neulet.2012.09.013.
29. O'Shea JJ, Holland SM, Staudt LM. 2013. JAKs and STATs in immunity, immunodeficiency, and cancer. N. Engl. J. Med. 368:161-170. http://dx .doi.org/10.1056/NEJMra1202117.
30. Doerfler ME, Weiss J, Clark JD, Elsbach P. 1994. Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2. J. Clin. Invest. 93:1583-1591. http://dx.doi.org/10.1172/JCI117138.
31. Rolling C, Treton D, Pellegrini S, Galanaud P, Richard Y. 1996. IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. FEBS Lett. 393:53-56. http://dx.doi.org/10.1016/0014-5793(96)00835-6.
32. Bhattacharjee A, Pal S, Feldman GM, Cathcart MK. 2011. Hck is a key regulator of gene expression in alternatively activated human monocytes. J. Biol. Chem. 286:36709-36723. http://dx.doi.org/10.1074/jbc.M111.291492.
33. Birzniece V, Sata A, Ho KK. 2009. Growth hormone receptor modulators. Rev. Endocr Metab. Disord. 10:145-156. http://dx.doi.org/10.1007/s11154-008-9089-x.
34. Scott KF, Bryant KJ, Bidgood MJ. 1999. Functional coupling and differential regulation of the phospholipase A2-cyclooxygenase pathways in inflammation. J. Leukoc. Biol. 66:535-541.
35. Tucker DE, Ghosh M, Ghomashchi F, Loper R, Suram S, John BS, Girotti M, Bollinger JG, Gelb MH, Leslie CC. 2009. Role of phosphorylation and basic residues in the catalytic domain of cytosolic phospholipase A2alpha in regulating interfacial kinetics and binding and cellular function. J. Biol.Chem. 284:9596-9611. http://dx.doi.org/10.1074/jbc.M807299200.
36. Habenicht AJ, Goerig M, Grulich J, Rothe D, Gronwald R, Schettler G, Kommerell B. 1985. The phospholipase C diglyceride lipase pathway contributes to arachidonic acid release and prostaglandin E2 formation in platelet-derived growth factor stimulated Swiss 3T3 cells. Adv. Prostaglandin Thromboxane Leukot. Res. 13:37-39.
37. Ishimoto T, Akiba S, Sato T, Fujii T. 1994. Contribution of phospholipases A2 and D to arachidonic acid liberation and prostaglandin D2 formation with increase in intracellular Ca2+ concentration in rat peritoneal mast cells. Eur. J. Biochem. 219:401-406. http://dx.doi.org/10.1111/j.1432-1033.1994.tb19952.x.
38. Moscat J, Herrero C, Garcia-Barreno P, Municio AM. 1986. Phospholipase C-diglyceride lipase is a major pathway for arachidonic acid release in macrophages. Biochem. Biophys. Res. Commun. 141:367-373. http://dx.doi.org/10.1016/S0006-291X(86)80378-3.
39. Noor S, Goldfine H, Tucker DE, Suram S, Lenz LL, Akira S, Uematsu S, Girotti M, Bonventre JV, Breuel K, Williams DL, Leslie CC. 2008. Activation of cytosolic phospholipase A2alpha in resident peritoneal macrophages by Listeria monocytogenes involves listeriolysin O and TLR2. J. Biol. Chem. 283:4744-4755. http://dx.doi.org/10.1074/jbc.M709956200.
40. Boussiotis VA, Barber DL, Nakarai T, Freeman GJ, Gribben JG, Bernstein GM, D'Andrea AD, Ritz J, Nadler LM. 1994. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science 266:1039-1042. http://dx.doi.org/10.1126/science.7973657.
41. Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu ZJ, Oishi I, Silvennoinen O, Witthuhn BA, Ihle JN, Taniguchi T. 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045-1047. http://dx.doi.org/10.1126/science.7973659.
42. Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M, Berg M, McVicar DW, Witthuhn BA, Silvennoinen O, Goldman AS, Schmalstieg FC, Ihle JN, O'Shea JJ, Leonard WJ. 1994. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266:1042-1045. http://dx.doi.org /10.1126/science.7973658.